451 related articles for article (PubMed ID: 25764777)
1. [Influence of toxin botulin on walk stereotype of children with juvenile cerebral palsy. The functional examination performed by BTS, comprehensive movement analysis system. A preliminary report].
Kwiecień-Czerwieniec I; Krukowska J; Woldańska-Okońska M
Wiad Lek; 2014; 67(2 Pt 1):59-63. PubMed ID: 25764777
[TBL] [Abstract][Full Text] [Related]
2. Effect of multilevel botulinum toxin a and comprehensive rehabilitation on gait in cerebral palsy.
Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
Pediatr Neurol; 2007 Jan; 36(1):30-9. PubMed ID: 17162194
[TBL] [Abstract][Full Text] [Related]
3. Functional outcomes of multilevel botulinum toxin and comprehensive rehabilitation in cerebral palsy.
Balbaloglu O; Basaran A; Ayoglu H
J Child Neurol; 2011 Apr; 26(4):482-7. PubMed ID: 21270468
[TBL] [Abstract][Full Text] [Related]
4. [Botulinum toxin in the management of spastic hip adductors in non-ambulatory cerebral palsy children].
Deleplanque B; Lagueny A; Flurin V; Arnaud C; Pedespan JM; Fontan D; Pontallier JR
Rev Chir Orthop Reparatrice Appar Mot; 2002 May; 88(3):279-85. PubMed ID: 12037484
[TBL] [Abstract][Full Text] [Related]
5. Application of botulinum toxin in treatment of spasticity and functional improvements for children suffering from cerebral palsy.
Meholjic A; Madjar D
Med Arh; 2010; 64(6):359-61. PubMed ID: 21218755
[TBL] [Abstract][Full Text] [Related]
6. A randomized controlled trial to compare two botulinum toxin injection techniques on the functional improvement of the leg of children with cerebral palsy.
Kaishou Xu ; Tiebin Yan ; Jianning Mai
Clin Rehabil; 2009 Sep; 23(9):800-11. PubMed ID: 19482892
[TBL] [Abstract][Full Text] [Related]
7. Effects of different dilutions of botulinum toxin type A treatment for children with cerebral palsy with spastic ankle plantarflexor: a randomized controlled trial.
Lee JH; Sung IY; Yoo JY; Park EH; Park SR
J Rehabil Med; 2009 Sep; 41(9):740-5. PubMed ID: 19774308
[TBL] [Abstract][Full Text] [Related]
8. [Botulinum A in the treatment of equinus dynamic spasticity in children with cerebral palsy. Preliminary study].
Mousny M; Allington N
Rev Chir Orthop Reparatrice Appar Mot; 1999 May; 85(2):156-63. PubMed ID: 10392416
[TBL] [Abstract][Full Text] [Related]
9. The combined effect of lower-limb multilevel botulinum toxin type a and comprehensive rehabilitation on mobility in children with cerebral palsy: a randomized clinical trial.
Scholtes VA; Dallmeijer AJ; Knol DL; Speth LA; Maathuis CG; Jongerius PH; Becher JG
Arch Phys Med Rehabil; 2006 Dec; 87(12):1551-8. PubMed ID: 17141633
[TBL] [Abstract][Full Text] [Related]
10. Effects of botulinum toxin A in ambulant adults with spastic cerebral palsy: a randomized double-blind placebo controlled-trial.
Maanum G; Jahnsen R; Stanghelle JK; Sandvik L; Keller A
J Rehabil Med; 2011 Mar; 43(4):338-47. PubMed ID: 21305227
[TBL] [Abstract][Full Text] [Related]
11. Functional outcome of botulinum toxin injection of gastrocnemius and adductors in spastic hemiplegic cerebral palsied children.
Ibrahim AI; Hawamdeh ZM; Al-Qudah AA
Eura Medicophys; 2007 Mar; 43(1):13-20. PubMed ID: 17021584
[TBL] [Abstract][Full Text] [Related]
12. [The results of single-event multilevel orthopedic surgeries and the early rehabilitation used in complex with botulinum toxin treatment in patients with spastic forms of cerebral palsy].
Popkov DA; Zmanovskaya VA; Gubina EB; Leonchuk SS; Butorina MN; Pavlova OL
Zh Nevrol Psikhiatr Im S S Korsakova; 2015; 115(4):41-48. PubMed ID: 26288287
[TBL] [Abstract][Full Text] [Related]
13. Changes of kinematics parameters of pelvis during walking under the influence of means facilitates treatment of cerebral palsied children.
Czupryna K; Nowotny J
Ortop Traumatol Rehabil; 2012; 14(5):453-65. PubMed ID: 23208937
[TBL] [Abstract][Full Text] [Related]
14. Randomised double blind placebo controlled trial of the effect of botulinum toxin on walking in cerebral palsy.
Ubhi T; Bhakta BB; Ives HL; Allgar V; Roussounis SH
Arch Dis Child; 2000 Dec; 83(6):481-7. PubMed ID: 11087280
[TBL] [Abstract][Full Text] [Related]
15. Botulinum toxin A in the management of spastic gait disorders in children and young adults with cerebral palsy: a randomized, double-blind study of "high-dose" versus "low-dose" treatment.
Wissel J; Heinen F; Schenkel A; Doll B; Ebersbach G; Müller J; Poewe W
Neuropediatrics; 1999 Jun; 30(3):120-4. PubMed ID: 10480205
[TBL] [Abstract][Full Text] [Related]
16. Botulinum A toxin for treatment of lower limb spasticity in cerebral palsy: gait analysis in 49 patients.
Papadonikolakis AS; Vekris MD; Korompilias AV; Kostas JP; Ristanis SE; Soucacos PN
Acta Orthop Scand; 2003 Dec; 74(6):749-55. PubMed ID: 14763710
[TBL] [Abstract][Full Text] [Related]
17. Computerized gait analysis of botulinum toxin treatment in children with cerebral palsy.
Galli M; Cimolin V; Valente EM; Crivellini M; Ialongo T; Albertini G
Disabil Rehabil; 2007 Apr; 29(8):659-64. PubMed ID: 17453987
[TBL] [Abstract][Full Text] [Related]
18. Intramuscular botulinum toxin prior to comprehensive rehabilitation has no added value for improving motor impairments, gait kinematics and goal attainment in walking children with spastic cerebral palsy.
Schasfoort F; Pangalila R; Sneekes EM; Catsman C; Becher J; Horemans H; Stam HJ; Dallmeijer AJ; Bussmann JBJ
J Rehabil Med; 2018 Aug; 50(8):732-742. PubMed ID: 30080235
[TBL] [Abstract][Full Text] [Related]
19. Botulinum toxin A injections do not improve surface EMG patterns during gait in children with cerebral palsy--a randomized controlled study.
van der Houwen LE; Scholtes VA; Becher JG; Harlaar J
Gait Posture; 2011 Feb; 33(2):147-51. PubMed ID: 21190858
[TBL] [Abstract][Full Text] [Related]
20. Treatment of cerebral palsy with botulinum toxin: evaluation with gross motor function measure.
Yang TF; Chan RC; Chuang TY; Liu TJ; Chiu JW
J Formos Med Assoc; 1999 Dec; 98(12):832-6. PubMed ID: 10634023
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
